Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes (Q46731741)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes |
scientific article |
Statements
1 reference
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes (English)
1 reference
1 reference
Cindy J Rubin
1 reference
Robert Frederich
1 reference
Kalyanee Viraswami-Appanna
1 reference
Kwo-Chuan Lin
1 reference
Rafael Montoro
1 reference
Gerald Shockey
1 reference
Jaime A Davidson
1 reference
1 August 2005
1 reference
1 reference
27
1 reference
8
1 reference
1181-1195
1 reference